Karyopharm Therapeut (KPTI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 81,461 | 84,908 | 136,252 | 72,431 | 83,394 |
| Marketable Securities | 155,871 | 176,322 | 142,779 | 77,030 | 88,598 |
| Receivables | 32,280 | 35,200 | 47,086 | 27,446 | 23,479 |
| Inventories | 3,672 | 3,827 | 4,224 | 4,249 | 3,470 |
| Other current assets | 0 | 0 | 0 | 31,468 | 32,078 |
| TOTAL | $291,381 | $318,541 | $350,162 | $222,677 | $242,447 |
| Non-Current Assets | |||||
| PPE Net | 766 | 849 | 1,139 | 1,252 | 1,395 |
| Other Non-Current Assets | 5,683 | 6,410 | 6,871 | 7,307 | 12,636 |
| TOTAL | $6,449 | $7,259 | $8,010 | $8,559 | $14,031 |
| Total Assets | $297,830 | $325,800 | $358,172 | $231,236 | $256,478 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,287 | 9,045 | 2,773 | 813 | 1,694 |
| Accrued Expenses | 51,808 | 47,032 | 58,415 | 55,716 | 56,367 |
| Other current liabilities | 1,749 | 2,501 | 1,848 | 2,462 | 1,865 |
| TOTAL | $58,928 | $61,555 | $65,908 | $61,761 | $62,541 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 310,150 | 309,419 | 308,920 | 309,755 | 310,275 |
| TOTAL | $310,150 | $309,419 | $308,920 | $309,755 | $310,275 |
| Total Liabilities | $369,078 | $370,974 | $374,828 | $371,516 | $372,816 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7,627 | 7,604 | 7,560 | 5,413 | 5,323 |
| Common Shares | 12 | 12 | 12 | 8 | 8 |
| Retained earnings | -1,410,695 | -1,378,065 | -1,343,939 | -1,305,433 | -1,269,109 |
| Other shareholders' equity | -783 | -419 | -638 | -752 | -538 |
| TOTAL | $-71,248 | $-45,174 | $-16,656 | $-140,280 | $-116,338 |
| Total Liabilities And Equity | $297,830 | $325,800 | $358,172 | $231,236 | $256,478 |